Junjiang H. Fu

Key Laboratory Of Epigenetics And Oncology
Luzhou, 646000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 167 publications

Targeting ADAM15 in cancer: from dual-faced biology to emerging therapies.

Targeting ADAM15 in cancer: from dual-faced biology to emerging therapies.

Journal: Drug discovery today

Published: April 14, 2026

Editorial Expression of Concern: Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation.

Editorial Expression of Concern: Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation.

Journal: Nature communications

Published: March 26, 2026

Sex determining region Y box protein 2 (SOX2) expression, alteration, regulation and its diagnostics, prognostics and therapeutics in lung cancer.

Sex determining region Y box protein 2 (SOX2) expression, alteration, regulation and its diagnostics, prognostics and therapeutics in lung cancer.

Journal: Discover oncology

Published: December 30, 2025

UBR5, a potential diagnostic and prognostic biomarker induces osteosarcoma progression.

UBR5, a potential diagnostic and prognostic biomarker induces osteosarcoma progression.

Journal: Pathology, research and practice

Published: October 09, 2025

DDX17-mediated raptor-dependent mTORC1 activation links autophagy inhibition and metabolic compensation in HCC development.

DDX17-mediated raptor-dependent mTORC1 activation links autophagy inhibition and metabolic compensation in HCC development.

Journal: Cellular & molecular biology letters

Published: September 30, 2025

WDR4 is a Potential Indicator of Clinical Diagnostics, Prognosis, and Immunotherapy in Hepatocellular Carcinoma (HCC).

WDR4 is a Potential Indicator of Clinical Diagnostics, Prognosis, and Immunotherapy in Hepatocellular Carcinoma (HCC).

Journal: Frontiers in bioscience (Landmark edition)

Published: August 13, 2025

A novel variant p.Y250C of FZD4 influences Norrine/β-catenin signaling pathway that associates with familial exudative vitreoretinopathy (FEVR).

A novel variant p.Y250C of FZD4 influences Norrine/β-catenin signaling pathway that associates with familial exudative vitreoretinopathy (FEVR).

Journal: Scientific reports

Published: August 03, 2025

Correction: Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2.

Correction: Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2.

Journal: Molecular biology reports

Published: July 10, 2025

Molecular biology research progress in post-mortem interval (PMI) estimation in forensic medicine.

Molecular biology research progress in post-mortem interval (PMI) estimation in forensic medicine.

Journal: International journal of legal medicine

Published: June 30, 2025

DHX36 plays an oncogenic role in breast cancer progression and invasiveness.

DHX36 plays an oncogenic role in breast cancer progression and invasiveness.

Journal: Scientific reports

Published: June 10, 2025

TQFL13, a novel synthetic derivative of thymoquinone (TQ), is more capable of inhibiting breast cancer progression than TQ.

TQFL13, a novel synthetic derivative of thymoquinone (TQ), is more capable of inhibiting breast cancer progression than TQ.

Journal: Bioorganic chemistry

Published: May 31, 2025

Novel Thymoquinone Derivative TQFL28 Inhibits Triple-Negative Breast Cancer (TNBC) Invasiveness In Vitro and In Vivo.

Novel Thymoquinone Derivative TQFL28 Inhibits Triple-Negative Breast Cancer (TNBC) Invasiveness In Vitro and In Vivo.

Journal: Current issues in molecular biology

Published: April 22, 2025

Showing 1-12 of 167

Last Updated: 09/26/2026